BRANDON, Fla., Jan. 31, 2016 -- Brandon Eye Associates has purchased a Lumenis Selecta Duet Laser to treat glaucoma patients. According to the Glaucoma Foundation, up to 3 million Americans have glaucoma, but may be unaware as the disease can develop with few symptoms. The Lumenis Selecta Duet is an advanced anterior segment laser that combines YAG photo disruption with Selective Laser Trabeculoplasty (SLT) technology.
SLT uses single pulse, short duration lasers to treat glaucoma. Selective Laser Trabeculoplasty replaces the previous treatment, Argon Laser Trabeculoplasty. SLT uses a lower-power laser to focus a beam of light to treat the drainage angle of the eye.
Lawrence C. Taylor Jr., M.D., of Brandon Eye Associates, believes this laser will enable them to offer better care for their patients who suffer from glaucoma. "Glaucoma is a condition in which pressure increases in the eyeball, eventually causing blindness. During a comprehensive eye exam, we perform several tests that screen for glaucoma, including an eye pressure test, peripheral vision tests, and a physical examination of the eye itself. When glaucoma is caught early, we can begin treatment that will help slow the rate in which vision loss occurs," stated Dr. Taylor.
Glaucoma is treated with eye drops, medications, and laser surgery. Trabeculoplasty is the most common type of laser surgery in the treatment of glaucoma. The laser is focused on the eye's drain and causes subtle changes allowing the aqueous fluid to pass more easily out of the drain.
According to Dr. Taylor, "Laser surgery is a great treatment option for our glaucoma patients. They can generally go home and return to normal activities within just a few hours. With our new Selecta Duet laser, we are able to provide very precise laser treatments in our office. It has several advanced features which allow us not only treat glaucoma, but also posterior capsule opacity, which is a condition that can occur after cataract surgery."
Glaucoma has no cure and is a leading cause of blindness if left untreated. Even with treatment, up to 10 percent of those diagnosed will experience some degree of vision loss. Individuals of every race and age are at risk of developing glaucoma. However, those who are diabetic or extremely nearsighted are at greater risk for developing blindness as a result of glaucoma.
Brandon Eye Associates has two locations: 540 Medical Oaks Avenue, Suite 103, Brandon, FL 33511 and 105 Southern Oaks Drive, Plant City, FL 33563. To make an appointment or to inquire about services, contact them at 813-666-8302. Their office hours are from 8:00 AM to 12:00 Noon, and from 1:00 PM to 5:00 PM, Monday through Friday. For more information, visit them online at www.brandoneyeassociates.com.
Brandon Eye Associates, 813-666-8302


Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 



